Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	Retention in HIV Care	Up to four years after baseline	The primary outcome is change in retention in HIV care between the intervention and control periods, where retention is defined as return for first follow-up visit within 3 months among newly enrolled adolescent clients OR follow-up visit after 're-engagement visit' (after lost-to-follow-up for \>90 days since last visit, with no record of death or transfer).
Secondary	Proportion of HCWs With Pass/Fail Scores	Up to one month after last day of training	The proportion of HCW participants who achieved competency upon completion of the training.
Secondary	Numeric Scores From SP Actors	Up to one week after last day of training	All SP actors will complete a check-list to provide non-technical feedback to each HCW participant. Scores will be used to compute the overall pass/fail score at completion of the training.
Secondary	Health Care Worker Competency	Baseline and every nine months for up to four years	This outcome is measured as change in mean competency score between intervention and control periods using a structured survey.
Secondary	Health Care Workers' Satisfaction With Skills	Baseline and every nine months for up to four years	This outcome is measured as change in mean satisfaction scores between intervention (post-training) and control periods (pre-training), using a structured survey. These surveys will be conducted at baseline, and every nine months at the end of the training in each wave. Exit interviews among trained participants will be conducted about one year after each training wave for up to four waves to complement the quantitative results.
Secondary	Adolescent Patients' Satisfaction With Care	Baseline and every nine months for up to four years	This outcome is defined as mean change in satisfaction score between intervention and control periods, using a structured survey.
Secondary	Retention in HIV Care (Secondary)	Baseline and every nine months for up to four years	A secondary measure of retention in HIV care is return for any follow-up visit within 3 months (90 days) among currently enrolled HIV-positive adolescent patients
Other	Antiretroviral (ART) Adherence in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in the proportion of visits with ART refills within 1 week of scheduled visit between intervention and control periods using available electronic medical record (EMR) data.
Other	Viral Load in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in viral load between intervention and control periods using available EMR data.
Other	Linkage to Adolescent Friendly Services in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in the proportion of visits with referrals to affiliated services (e.g. family planning) between intervention and control periods using available EMR data.
Other	AIDS Defining Illness in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in the proportion of visits with any AIDS defining illness between intervention and control periods using available EMR data.
Other	Mortality in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in the proportion of deaths between intervention and control periods using available EMR data.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02928900/registered

API reference For AI assistants